QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Gemini Therapeutics
(NASDAQ:GMTX)
1.36
00
At close: May 23
1.36
00
PreMarket: 4:51PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low1.16 - 12.95
Open / Close- / -
Float / Outstanding22.4M / 43.2M
Vol / Avg.- / 312.7K
Mkt Cap58.8M
P/E-
50d Avg. Price1.47
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float22.4M

Gemini Therapeutics (NASDAQ:GMTX), Quotes and News Summary

Gemini Therapeutics (NASDAQ: GMTX)

Day High/Low- - -
52 Week High/Low1.16 - 12.95
Open / Close- / -
Float / Outstanding22.4M / 43.2M
Vol / Avg.- / 312.7K
Mkt Cap58.8M
P/E-
50d Avg. Price1.47
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float22.4M
Benzinga - Apr 14, 2022, 9:35AM
Benzinga - Apr 13, 2022, 4:17PM
Benzinga - Apr 13, 2022, 4:13PM
Benzinga - Mar 11, 2022, 6:46AM
Benzinga - Mar 10, 2022, 7:14AM
Benzinga - Mar 3, 2022, 6:30AM
Benzinga - Mar 1, 2022, 12:48PM
Benzinga - Mar 1, 2022, 6:15AM
Benzinga - Feb 28, 2022, 8:32AM
Benzinga - Jan 24, 2022, 4:28AM
Benzinga - Dec 20, 2021, 4:50AM
Benzinga - Dec 15, 2021, 1:42PM
Benzinga - Dec 15, 2021, 10:20AM
Benzinga - Dec 15, 2021, 8:11AM
Benzinga - Dec 15, 2021, 6:45AM
Benzinga - Nov 15, 2021, 7:30AM
Benzinga - Oct 19, 2021, 7:22AM
Benzinga - Oct 6, 2021, 8:12AM
load more
Sector: Health Care.Industry: Biotechnology
Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. Variations in the gene that encodes CFH strongly correlate with an increased risk of developing AMD.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.300-0.350 -0.0500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Gemini Therapeutics Questions & Answers

Q
How do I buy Gemini Therapeutics (GMTX) stock?
A

You can purchase shares of Gemini Therapeutics (NASDAQ: GMTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Gemini Therapeutics's (GMTX) competitors?
Q
What is the target price for Gemini Therapeutics (GMTX) stock?
A

The latest price target for Gemini Therapeutics (NASDAQ: GMTX) was reported by HC Wainwright & Co. on Friday, March 11, 2022. The analyst firm set a price target for 2.00 expecting GMTX to rise to within 12 months (a possible 47.06% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Gemini Therapeutics (GMTX)?
A

The stock price for Gemini Therapeutics (NASDAQ: GMTX) is $1.36 last updated May 23, 2022, 8:00 PM UTC.

Q
Does Gemini Therapeutics (GMTX) pay a dividend?
A

There are no upcoming dividends for Gemini Therapeutics.

Q
When is Gemini Therapeutics (NASDAQ:GMTX) reporting earnings?
A

Gemini Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Gemini Therapeutics (GMTX) going to split?
A

There is no upcoming split for Gemini Therapeutics.

Q
What sector and industry does Gemini Therapeutics (GMTX) operate in?
A

Gemini Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.